OGN · Organon & Co. · Metrics
$13.90
+0.00 (+0.00%)
At close · Nov 17
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Market Cap
$3.65B
Shares
262.62M
Volume · Nov 17
4.16M
Avg daily vol (3M)
2.71M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
OGN metrics
105 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$13.90
Market cap
$3.65B
Price action
23 metricsPrice change (1W)
+0.1%
Price change (30D)
+1.1%
Price change (3M)
+1.6%
Price change (6M)
+3.6%
Price change (YTD)
+93.9%
Price change (1Y)
+81.7%
Trailing year
Price change (5Y)
-57.8%
52-week high
$13.90
52-week low
$5.70
Change from 52-week high
+0.0%
Change from 52-week low
+143.9%
Annualized volatility
58.2%
Annualized volatility (3M)
3.0%
Implied volatility (30D)
9.7%
IV rank (1Y)
0.5
IV percentile (1Y)
0.7
Beta
0.6
RSI (14D)
65.8
Price vs SMA 50
+1.0%
Price vs SMA 200
+17.7%
Avg volume (3M)
2.71M
Relative volume
1.5
Average dollar volume
$37.24M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
262.62M
Valuation
12 metricsP / E (TTM)
18.1
Trailing earnings · reciprocal yield 5.5%
PEG ratio
—
EV / revenue
1.8×
reciprocal yield 56.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 167.1%
P / book
3.1
reciprocal yield 32.7%
FCF yield
18.5%
TTM · current market cap
Buyback yield
—
P / FCF
5.4
reciprocal yield 18.5%
P / operating cash flow
4.3
reciprocal yield 23.1%
Earnings yield
5.8%
Historical valuation
8 metricsP / E historical average (3Y)
7.6×
reciprocal yield 13.1%
P / E historical average (5Y)
7.4×
reciprocal yield 13.4%
EV / revenue historical average (3Y)
1.8×
reciprocal yield 54.5%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 48.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
0.7%
Trailing 12 months
Payout ratio
9.4%
Shareholder yield
0.5%
Dividend / share (TTM)
$0.10
Dividend growth YoY
-68.8%
Dividend growth streak
0
Last ex-dividend
2026-11-09
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-04-30
Profitability
9 metricsGross margin
53.1%
Operating margin
—
Trailing 12 months
Net margin
3.5%
Gross profit (TTM)
$3.24B
Operating profit (TTM)
—
Net income (TTM)
$213.00M
Trailing 12 months
Diluted EPS (TTM)
$0.77
FCF margin
11.1%
Effective tax rate
57.7%
Growth
11 metricsRevenue growth YoY
-1.7%
Year over year
Net income growth YoY
+2.5%
Revenue (TTM)
$6.10B
Trailing 12 months
EPS growth YoY
-1.6%
Shares change YoY
+4.5%
Year over year · more shares
Revenue CAGR (3Y)
+0.2%
Revenue CAGR (5Y)
-1.0%
EPS CAGR (3Y)
-41.5%
EPS CAGR (5Y)
-39.0%
FCF CAGR (3Y)
-6.7%
FCF CAGR (5Y)
-23.3%
Quality
14 metricsReturn on equity
17.9%
Return on assets
1.6%
Debt / equity
7.2
Current ratio
2.0
EBITDA (TTM)
—
Free cash flow (TTM)
$675.00M
Quick ratio
1.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$7.10B
Latest balance sheet
Cash & equivalents
$1.46B
Total assets
$13.40B
Total debt
$8.55B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$843.00M
Capital expenditures (TTM)
$168.00M
R&D (TTM)
$357.00M
SG&A (TTM)
$1.71B
Stock compensation (TTM)
$72.00M
R&D / revenue
5.9%
Stock compensation / revenue
1.2%
Ownership (13F)
9 metrics13F filers
607
13F filer change QoQ
-34
Institutional ownership
86.1%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
31.9%
Private-fund adviser ownership
26.0%
Active holders' share change QoQ
+6.3%
Holder tenure
9.8
Price vs estimated holder cost
-16.6%
Ownership (registered funds)
1 metricsIndex-fund ownership
27.1%
Short interest
3 metricsShort interest
7.5%
Latest settlement · 8.5 days to cover
Days to cover
8.5d
Short-squeeze score
65 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1821825
CUSIP
68622V106
13F (30d)
642 filings
554 filers
Visit website
Investor relations